NUT Carcinoma
Conditions
Interventions
A group of midline cancer cases with nuclear protein in testis (NUT) gene rearrangement:None
Sponsors
Chongqing University Three Gorges Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. All patients were diagnosed with NUT cancer through histopathological examination 2. All patients have analyzable treatment and follow-up data (including imaging data and detailed medical records)
Exclusion criteria
Exclusion criteria: 1. Patients with unclear pathological diagnosis or inability to obtain NUT gene fusion test results. 2. Patients who have combined other malignant tumors and cannot clearly identify NUT cancer as the primary diagnosis. 3. Patients who are unable to provide sufficient biological samples or refuse to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival (PFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| OS, Overall Survival;Clinical and pathological characteristics;Therapeutic information;Immunohistochemical (IHC) results; | — |
Countries
China
Contacts
Public ContactMingzhu Yin
Chongqing University Three Gorges Hospital
Outcome results
None listed